# Testing an Innovative Biomarker: Expression of HIF-1α and Its Isoforms in the Blood and Skin Tissue of Major Burns

> **NCT02870439** · NA · UNKNOWN · sponsor: **Assistance Publique Hopitaux De Marseille** · enrollment: 45 (estimated)

## Conditions studied

- Burn Injuries

## Interventions

- **OTHER:** Blood drawn

## Key facts

- **NCT ID:** NCT02870439
- **Lead sponsor:** Assistance Publique Hopitaux De Marseille
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2012-10
- **Primary completion:** 2016-10
- **Final completion:** 2017-10
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2016-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02870439

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02870439, "Testing an Innovative Biomarker: Expression of HIF-1α and Its Isoforms in the Blood and Skin Tissue of Major Burns". Retrieved via AI Analytics 2026-09-08 from https://api.ai-analytics.org/clinical/NCT02870439. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*